SIRT1 and metabolic dysfunction-associated steatotic liver disease: SIRT1 inhibited hepatic inflammation, ER stress, and lipogenesis, indicating that SIRT1 could improve NAFLD [57,58,59,60] and possessed a beneficial metabolic function [61].